Announcement on the Progress of Tianjin Boguang Yijian Biotechnology Development Co., Ltd.'s Plan to Transfer 50.98% Equity of its Controlling Subsidiary Lianyungang Wantai Pharmaceutical Auxiliary Material Technology Co., Ltd. through Listing